Evaluation of the Efficacy of Artificial Intelligence-Based Screening for Diabetic Retinopathy in a Predominantly Non-White Population
{{output}}
Objective: To evaluate the diagnostic accuracy of Luminetics Core, a Food and Drug Administration-cleared artificial intelligence-based screening system, in the detection of diabetic retinopathy (DR) in a predominately non-White ... ...
